ArticleAsian Pacific journal of cancer prevention : APJCP2025
Transforming Intraoperative Breast Cancer Diagnosis through D-FFOCT and AI Integration.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This editorial discusses the transformative potential of integrating dynamic full-field optical coherence tomography (D-FFOCT) with artificial intelligence (AI) in intraoperative breast cancer diagnosis. Traditional methods, such as frozen pathology, often face limitations in speed and accuracy, which can impact surgical outcomes. D-FFOCT, offering high-resolution, real-time imaging of tissue microstructures without ionizing radiation, presents a non-destructive alternative that maintains specimen integrity. Coupled with AI, particularly deep learning algorithms, this technology has demonstrated impressive diagnostic accuracy and speed, significantly reducing intraoperative margin evaluation time. Despite challenges in implementing these innovations, such as the need for high-quality datasets and addressing algorithmic bias, the integration of D-FFOCT and AI promises to enhance decision-making, alleviate the burden on pathologists, and improve patient outcomes. This approach not only aims to optimize breast cancer surgeries but also has broader implications for the diagnosis and treatment of other tumor types, highlighting the importance of ethical considerations and collaborative efforts in advancing clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.